MLchartDataset catalogue

motesanib diphosphate

Term · Oncology and biomedicine · MLC-T-ONC-015287

The orally bioavailable diphosphate salt of a multiple-receptor tyrosine kinase inhibitor with potential antineoplastic activity. Motesanib selectively targets and inhibits vascular endothelial growth factor (VEGFR), platelet-derived growth factor (PDGFR), kit, and Ret receptors, thereby inhibiting angiogenesis and cellular proliferation.

Table 1. Record
IdentifierMLC-T-ONC-015287
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-015287",
  "term": "motesanib diphosphate",
  "field": "Oncology and biomedicine",
  "definition": "The orally bioavailable diphosphate salt of a multiple-receptor tyrosine kinase inhibitor with potential antineoplastic activity. Motesanib selectively targets and inhibits vascular endothelial growth factor (VEGFR), platelet-derived growth factor (PDGFR), kit, and Ret receptors, thereby inhibiting angiogenesis and cellular proliferation.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/motesanib-diphosphate/"
}

Record 11,288 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.